|
Volumn 171, Issue 1, 2014, Pages 90-92
|
Successful treatment of a patient with symptomatic long QT syndrome type 3 using ranolazine combined with a beta-blocker
|
Author keywords
Beta blocker; Late inward sodium current; Long QT syndrome type 3; N1325S; Ranolazine; SCN5a
|
Indexed keywords
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
PROPRANOLOL;
RANOLAZINE;
SODIUM CHANNEL NAV1.5;
SOTALOL;
ADULT;
CASE REPORT;
DNA DETERMINATION;
EXERCISE TEST;
FEMALE;
GENE MUTATION;
HEART VENTRICLE EXTRASYSTOLE;
HEART VENTRICLE TACHYCARDIA;
HOLTER MONITORING;
HUMAN;
LETTER;
LONG QT SYNDROME 3;
PRIORITY JOURNAL;
SCN5A GENE;
SUPRAVENTRICULAR PREMATURE BEAT;
SUPRAVENTRICULAR TACHYCARDIA;
T WAVE;
BETA-BLOCKER;
LATE INWARD SODIUM CURRENT;
LONG QT SYNDROME TYPE 3;
N1325S;
RANOLAZINE;
SCN5A;
ACETANILIDES;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
DRUG THERAPY, COMBINATION;
ELECTROCARDIOGRAPHY, AMBULATORY;
FEMALE;
HUMANS;
LONG QT SYNDROME;
PIPERAZINES;
SODIUM CHANNEL BLOCKERS;
TREATMENT OUTCOME;
|
EID: 84891735675
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2013.11.066 Document Type: Article |
Times cited : (16)
|
References (10)
|